Search SciPol

Brought to you by
What it does 

ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing) is a new industry offering, promoted as “the only FDA-cleared concussion assessment aid for ages 5-59.” The tool is a computerized concussion management program, designed to provide a guideline for concussion evaluation, ultimately enabling a licensed healthcare provider to diagnose a concussion, inform treatment, and consider if/when an athlete may return to play. The ImPACT test format consists of baseline and post-injury assessments, available for children ages 5-11 years, as well as those aged 12-59 years:

1) Baseline test - Before a sports season starts, each student or professional athlete takes a baseline test, to establish how one’s brain functions in normal, everyday circumstances. This assessment takes approximately 25 minutes to complete and is then stored in the company’s data server, which is compliant with the U.S. Health Insurance Portability and Accountability Act (HIPAA), Canada’s Personal Information Protection and Electronic Documents Act (PIPEDA), and the EU’s General Data Protection Regulation (GDPR).

2) Post-injury test - In the event an individual sustains a head injury and is at-risk for concussion, this person takes a post-injury test; the results are compared to the baseline scores and/or normative data scores by a licensed health care provider who will determine whether the individual has sustained a concussion and if/when the injured person may return-to-play. If an athlete scores substantially lower on the post-injury test than the baseline score, the athlete will not be allowed to return-to-play until the post-injury test scores return to the level of one’s baseline.

This program evaluates multiple aspects of neuropsychological function, including: health history; inventory of concussion-related symptoms such as headache and mental fogginess; attention span; motor processing speed; reaction time; working memory; non-verbal problem solving; and impulse control.

Since 2006, over 7.5 million individuals around the world have taken the ImPACT test. According to ImPACT, the tool is currently used by 7,400 high schools and 1,000 colleges and universities to help evaluate and manage suspected concussions. Schools and teams subscribe on an annual basis; package prices are set according to varying test quantities (e.g., 135 baselines and 15 post-injury tests cost $435 per year). Healthcare providers purchase tests on an individual basis ($12 per baseline; $24 per post-injury). For an additional fee, company neuropsychologists offer test interpretation.  The ImPACT Passport Mobile App also allows parents and test takers to store baseline test results, which can be provided to Passport trained healthcare providers for purposes of post injury comparative evaluation.

Relevant Science 

The brain is a soft organ that is surrounded by a clear fluid called cerebrospinal fluid (CSF) and protective membranes, called meninges. Normally, the fluid around the brain functions like a cushion that keeps the brain from banging into the skull. A blow to the head or body, a fall, or another injury that jars or shakes the head and body, can cause your brain to be pushed against the skull, thereby bruising the brain and tearing nerve tissues, ultimately resulting in a concussion. This condition is a form of mild Traumatic Brain Injury (TBI), which can cause a temporary disturbance in brain function. Since the brain is a complex organ that processes sensory information and ultimately controls our senses and movements, giving us the ability to feel and think, a brain injury can cause a broad range of impairments in physiological and psychological functions.

Effects of a concussion are usually temporary, but in rare instances can last over a year. Symptoms of a concussion can be categorized into four groups, which manifest in the following ways:

  • Thinking and remembering
    • Not thinking clearly
    • Feeling slowed down
    • Not being able to concentrate
    • Not being able to remember new information
    • Inability to remember what happened immediately before or after the injury (amnesia)
    • Loss of consciousness
  • Physical
    • Nausea and vomiting
    • Headache
    • Fuzzy or blurry vision
    • Dizziness
    • Sensitivity to light or noise
    • Balance problems
    • Feeling tired or having no energy
    • Ringing in the ears (tinnitus)
  • Emotional and mood
    • Easily upset or angered
    • Sad
    • Nervous or anxious
    • More emotional
  • Sleep
    • Sleeping more than usual
    • Sleeping less than usual
    • Having a hard time falling asleep

Any person who suspects they may have a concussion needs to see a healthcare provider for official diagnosis. If a clinician thinks that you have a concussion, they will ask questions about the injury and may also test your attention, learning ability, and memory. They may also check your strength, balance, coordination, reflexes, and sensation.

A healthcare practitioner may also use neuropsychological tests to assess whether a concussion impacts your physical and psychological functioning, usually determined through the use of questionnaires. Sometimes a doctor may order brain imaging tests such as a Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI), to assess whether the brain is bruised or bleeding.

In 2012, an estimated 329,290 children (age 19 or younger) were treated in U.S. emergency rooms for sports and recreation-related injuries that included a diagnosis of concussion or TBI.

It’s particularly important that athletes don't return to play until they are fully recovered, since doing so too soon can increase an athlete's chances of developing a persistent head injury called Second Impact Syndrome (SIS), “a condition so rare that even the frequency of its occurrence is in question.” SIS is a situation in which a second head injury occurs before a first concussion has properly healed, causing rapid and severe brain swelling and brain herniation. SIS can occur with any two events involving head trauma. Most cases of SIS have occurred in young athletes, particularly those who participate in sports such as boxing, baseball, football, hockey, and skiing. It can occur in the same game or competition if the athlete isn’t removed and treated after the first concussion. Symptoms usually occur immediately following the second impact and progress rapidly. Common symptoms include: dilated pupils, loss of eye movement, loss of consciousness, respiratory failure, and death.

Why It Matters 

Public concern regarding sports-related concussions is on the rise; this topic is garnering increased attention from the media, professional sports leagues, as well as law and policy-making bodies. Before the creation of ImPACT, widespread use of a standardized concussion assessment tool was lacking. Historically, those who sustained head injuries have often been responsible for self-reporting a suspected concussion. Return-to-play standards and guidelines have also been variably implemented.

Concussions and traumatic brain injuries have increasingly received national attention. In 2013, former professional football players reached a $765 million settlement against the NFL; they claimed to have memory loss, depression, headaches, and dizziness after suffering from multiple head injuries over the course of their careers. It’s not just athletes; the U.S. Department of Defense estimates that 22 percent of all combat injuries in the Iraq and Afghanistan conflicts are traumatic brain injuries.

Relevant Experts 

Jeffrey R Bytomski, DO, FAOASM, is a sport medicine specialist and physiatrist at Duke Health. His clinical interests include non-operative musculoskeletal medicine as well as medical issues in athletes, including concussions and post-concussion syndrome. He helps coordinate the Duke Sports Concussion Clinic. He also performs compartment pressure testing for evaluation of chronic exertional compartment syndrome. He is a certified ImPACT consultant for concussions, and offers baseline concussion testing for athletes. Relevant publications include:

Barry Myers, M.D., PhD., MBA., is a professor of Biomedical Engineering and director of research at Duke Clinical & Translational Science Institute (CTSI). His research examines the biomechanics of head and neck injury with the goal of injury prevention. At Duke CTSI, he consults the service that provides funding and project management support to faculty translational research projects in the Duke Medical Center. Dr. Myers also created and leads a national translational research fund intended to reduce injuries in professional football. Relevant publications include:


ImPACT is not the only available concussion assessment tool. Others include:

1. The Sport Concussion Assessment Tool (SCAT) - Evaluates people who are possibly suffering from sports concussions; used in athletes starting at 13 years old. The original SCAT was produced in 2004 as part of the Summary and Agreement Statement of the Second International Symposium on Concussion in Sport (CIS; published in 2005); SCAT2 and SCAT3 were updated in 2009 and 2017, respectively (at subsequent CIS conferences). Child-SCAT3 may be used for children 5 to 12 years old and can be downloaded for free.

The SCAT3 score does not independently determine the diagnosis of a concussion, nor does it independently determine the injured athlete’s recovery or return to play status. Such determination can only be made by a medical professional who has training and experience in treating sport concussions. The SCAT3 measures the following sections: symptom evaluation, cognitive assessment-Standardized Assessment of Concussion (SAC), balance examination, coordination examination. The SCAT 3 has a graded symptom scale going from 0 (indicating no symptoms), 1 (very mild), up to 6 (severe). This tool can also be used for pre-season baseline assessments, to be compared to future post-injury test scores.

2. The Standardized Assessment of Concussion (SAC) - Provides immediate cognitive screening for athletes who may have incurred a concussion. The test contains questions designed to assess athletes' orientation, immediate memory, concentration, and delayed memory. It also includes an exertion test and brief neurological evaluation. The SAC takes approximately 5 -7 minutes to administer and does not require a neuropsychologist to evaluate test scores. However, because it tests only for verbal memory, the SAC cannot identify athletes who may suffer measurable impairment of neurocognitive function (primarily visual working memory) on neurocognitive tests. The SAC is not meant to replace comprehensive neuropsychological testing or to be used as a stand-alone tool to diagnose concussions, measure recovery, or make decisions about an athlete's readiness to return to competition. 

3. Automated Neuropsychological Assessment Metrics (ANAM) - Detects the accuracy and efficiency of cognitive processing through a computer-based neuropsychological assessment tool. ANAM measures attention, concentration, reaction time, memory, processing speed, and decision making. Test results can be used for healthcare professionals to assess cognitive change that may have been caused by injury, fatigue, illness, exposure, or medical intervention.

4. The Glasgow Coma Scale (GCS) - Describes a person’s level of consciousness following a traumatic brain injury (TBI) by using a common scoring system. It is used to help gauge the severity of an acute brain injury, but not cognitive function. The GCS is scored between 3 and 15; 3 being the worst and 15 the best. The GCS measures eye opening, verbal response, and motor response.

5. King-Devick Tests - Measures eye movements, along with the speed and accuracy of naming numbers. These tasks detect impairments of eye movements, attention, language, and other indicators that correlate with suboptimal brain function. The Mayo Clinic endorses this method as an accurate screening test to determine whether an athlete should be sidelined. This test takes approximately two minutes to complete.

Endorsements & Opposition 


  • The Center Foundation, located in Oregon, provides the ImPACT tests for free to Central Oregon athletes in high-risk sports in order to comply with requirements of Max’s Law, a state requirement that Oregon school districts implement concussion management plans for athletes.
  • The Nebraska Sports Concussion Network funded baseline testing for 7th through 12th grade athletes participating in collision and contact sports with the highest incidence of concussions, including football, volleyball, basketball, wrestling, diving, soccer, track-jumpers, baseball, and softball; 75% of all Nebraska high schools are using the tool.
  • Some professional sports teams use the tool, including the National Football League (NFL), National Basketball Association (NBA), National Hockey League (NHL), and Major League Baseball (MLB).
  • Collegiate level teams are also signing up to use the tool, including numerous National Collegiate Athletic Association (NCAA) Division I football programs. Other athletic programs in Nebraska are currently implementing the program, such as, Doane College, Concordia University, Peru State College, UNO, and UNK.


A number of studies and experts question the validity and reliability of ImPACT testing. These studies suggest that an ImPACT test should not be a superior measure to diagnose lingering concussion symptoms or to judge when an individual is fully recovered. Also, using a multifaceted approach is suggested. Reasons include:

  • Michael Barlow and his colleagues at Walsh University showed that reliability of the test is unacceptably low by arguing that interpretation of test scores is difficult. Observation of a drop in the score for reaction time cannot be directly connected to brain impairment because many conditions affect test performance, such as a person’s lack of sleep or high level of caffeine consumption. Further, ImPACT administrators may not have been trained professionally in neuropsychological testing or data interpretation. Also, because an adolescent brain is still immature, differences in scores from one test to the next could be attributable to other factors influencing brain development.

In August, 2016, the U.S. Food and Drug Administration permitted the marketing of ImPACT and ImPACT Pediatric for assessment of cognitive function following a possible concussion. This class II medical device was reviewed via the FDA’s de novo classification pathway, which allows for classification of novel, low- to-moderate-risk medical devices that are first-of-a-kind, but have reasonable assurance of safety and efficacy. FDA codified the classification of the device by adding “Computerized cognitive assessment aid for concussion” as a new category of Neurological Diagnostic Device (21 CFR 882.1471).


ImPACT is manufactured by ImPACT Applications, located in Pittsburgh, Pennsylvania. ImPACT is a research-based software tool developed by neuropsychologist Mark Lovell, the CEO of ImPACT Applications Inc., along with University of Pittsburgh neurosurgeon Joseph Maroon. 

Primary Author 
EunYoung Song, PhD
Aubrey Incorvaia, MPP, Andrew Pericak, MEM
Recommended Citation 

Duke SciPol, “Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT)” available at (6/23/2017).

Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Please distribute widely but give credit to Duke SciPol and the primary author(s) listed above, linking back to this page if possible.